
Stimulates pituitary GH release to reduce visceral belly fat, improve body composition, and support metabolic health.
A growth hormone-releasing peptide specifically studied for reducing stubborn visceral belly fat — the dangerous fat surrounding your organs linked to heart disease and metabolic syndrome. FDA-approved in its pharmaceutical form (Egrifta), making it one of the most evidence-backed research peptides available.